ConductScience.org, home

Paper33333744

Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.

Bellini C and 1 other. Cells, 2020. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis. Papers, record 33333744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33333744

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.
PubMed
Journal
Cells
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.46
iCite
Revised in PubMed
2021-06-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bellini CChiara
2Horváti KKatahttps://orcid.org/0000-0003-4092-6011

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PeptidesMajor topic
ProteinsMajor topic
TuberculosisMajor topic
Tuberculosis VaccinesMajor topic
Vaccines, SubunitMajor topic
Amino Acid Sequence
Humans

Source PubMed

Download CSV of topics

References96

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131266253Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems Against Group A Streptococcus.Vaccines (Basel)2019https://conductscience.org/library/papers/31266253PubMed
223410889Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.Tuberculosis (Edinb)2013https://conductscience.org/library/papers/23410889PubMed
332174919Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology.Front Immunol2020https://conductscience.org/library/papers/32174919PubMed
432082273Clinical Development of New TB Vaccines: Recent Advances and Next Steps.Front Microbiol2019https://conductscience.org/library/papers/32082273PubMed
529920369Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches.Int J Biol Macromol2018https://conductscience.org/library/papers/29920369PubMed
623391465Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.Lancet2013https://conductscience.org/library/papers/23391465PubMed
725288770Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25288770PubMed
827448625Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.Hum Vaccin Immunother2016https://conductscience.org/library/papers/27448625PubMed
929567319In silico design of Mycobacterium tuberculosis epitope ensemble vaccines.Mol Immunol2018https://conductscience.org/library/papers/29567319PubMed
1031849981CD4+ T Responses Other Than Th1 Type Are Preferentially Induced by Latency-Associated Antigens in the State of Latent Mycobacterium tuberculosis Infection.Front Immunol2019https://conductscience.org/library/papers/31849981PubMed
1132437659Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.Cell2020https://conductscience.org/library/papers/32437659PubMed
1231064713Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide.Tuberculosis (Edinb)2019https://conductscience.org/library/papers/31064713PubMed
1329545464Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients.Clin Cancer Res2018https://conductscience.org/library/papers/29545464PubMed
1415126436Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study.JAMA2004https://conductscience.org/library/papers/15126436PubMed
1529051764Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination.Front Immunol2017https://conductscience.org/library/papers/29051764PubMed
1624717628Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.Lancet Respir Med2014https://conductscience.org/library/papers/24717628PubMed
1710919651Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.Cancer Res2000https://conductscience.org/library/papers/10919651PubMed
1832359402Considering BCG vaccination to reduce the impact of COVID-19.Lancet2020https://conductscience.org/library/papers/32359402PubMed
1923103299A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.Vaccine2012https://conductscience.org/library/papers/23103299PubMed
2010898510Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen.Eur J Immunol2000https://conductscience.org/library/papers/10898510PubMed

See all 96 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
41889758Chemical Strategy and AI-Enabled Peptide Vaccine Development.JACS Au2026https://conductscience.org/library/papers/41889758PubMed
40959074Tuberculosis in patients with systemic lupus erythematosus.Front Immunol2025https://conductscience.org/library/papers/40959074PubMed
40038239Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40038239PubMed
39841361Tuberculosis vaccines and therapeutic drug: challenges and future directions.Mol Biomed2025https://conductscience.org/library/papers/39841361PubMed
39340027Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice.Vaccines (Basel)2024https://conductscience.org/library/papers/39340027PubMed
39323805In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines.Heliyon2024https://conductscience.org/library/papers/39323805PubMed
38459038BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice.NPJ Vaccines2024https://conductscience.org/library/papers/38459038PubMed
38022657Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates.Front Immunol2023https://conductscience.org/library/papers/38022657PubMed
37626082An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis.NPJ Vaccines2023https://conductscience.org/library/papers/37626082PubMed
37606258Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection.Bioconjug Chem2023https://conductscience.org/library/papers/37606258PubMed
37371548ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis.Biomolecules2023https://conductscience.org/library/papers/37371548PubMed
36992193A Multistage Antigen Complex Epera013 Promotes Efficient and Comprehensive Immune Responses in BALB/c Mice.Vaccines (Basel)2023https://conductscience.org/library/papers/36992193PubMed
36839774Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy.Pharmaceutics2023https://conductscience.org/library/papers/36839774PubMed
36672252A Structural View at Vaccine Development against M. tuberculosis.Cells2023https://conductscience.org/library/papers/36672252PubMed
36551264Proteome Profile Changes Induced by Heterologous Overexpression of Mycobacterium tuberculosis-Derived Antigens PstS-1 (Rv0934) and Ag85B (Rv1886c) in Mycobacterium microti.Biomolecules2022https://conductscience.org/library/papers/36551264PubMed
36497063Molecular Immunology in Bacterial Vaccine Discovery.Cells2022https://conductscience.org/library/papers/36497063PubMed
36159845Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.Front Immunol2022https://conductscience.org/library/papers/36159845PubMed
35173740Peptide-Based Vaccines for Tuberculosis.Front Immunol2022https://conductscience.org/library/papers/35173740PubMed
34069535Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines.Vaccines (Basel)2021https://conductscience.org/library/papers/34069535PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene
TLR954106PubTator's text mininghttps://conductscience.org/library/genes/54106NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33333744

GET https://conductscience.org/api/papers/v1/33333744/references?page=2